Dr. Subhaprakash Sanyal Director, Haemato-Oncology & Bone Marrow Transplant, Fortis Hospital, Mulund
Manage this InformationLocations
Mumbai
India
Education and Training
Calcutta National Medical College And Hospital
MBBS
- 1999
King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai
DM - Hematology
- 2010
Jawaharlal Institute of Postgraduate Medical Education & Research, Pondicherry
MD
Top hcps in Mumbai
How can I make an appointment with Dr. Subhaprakash Sanyal?
You can view Dr. Subhaprakash Sanyal's profile on MedSynapse to make an appointment.
What is Dr. Subhaprakash Sanyal's top areas of care?
Dr. Subhaprakash Sanyal's top areas of care are Anemia, Deep vein thrombosis (blood clots), Leukemia, lymphoma, or multiple myeloma (cancers in your bone marrow, lymph nodes, or white blood cells), Sepsis, a dangerous reaction to an infection, Hemophilia, Sickle cell disease.
Who is Dr. Subhaprakash Sanyal?
Dr. Subhaprakash Sanyal is Hematologist in Mumbai. Dr. Subhaprakash Sanyal is affiliated with medical facilities such as Fortis Hiranandani Hospital, Fortis Hospital, Mulund and many more. Dr. Subhaprakash Sanyal graduated from Calcutta National Medical College And Hospital, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai and many more.
What is Dr. Subhaprakash Sanyal's education qualification?
Dr. Subhaprakash Sanyal graduated from Calcutta National Medical College And Hospital, King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, Mumbai and many more.
Where does Dr. Subhaprakash Sanyal work?
Dr. Subhaprakash Sanyal is affiliated with medical facilities such as Fortis Hiranandani Hospital, Fortis Hospital, Mulund and many more.
Why do patients visit Dr. Subhaprakash Sanyal?
Patients frequently visit Dr. Subhaprakash Sanyal for Anemia, Deep vein thrombosis (blood clots), Leukemia, lymphoma, or multiple myeloma (cancers in your bone marrow, lymph nodes, or white blood cells), Sepsis, a dangerous reaction to an infection, Hemophilia, Sickle cell disease.
